Renal transplantation in patients with hepatitis C virus antibody. A long national experience

NDT Plus

Volumn 3, Issue SUPPLL. 2, 2010, Pages

  Morales, Jose María ^a   Marcén, Roberto ^b   Andres, Amado ^a   Domínguez Gil, Beatriz ^c   Campistol, Josep María ^d   Gallego, Roberto ^e   Gutierrez, Alex ^f   Gentil, Miguel Angel ^g   Oppenheimer, Federico ^d   Samaniego, María Luz ^h   Muñoz Robles, Jorge ^h   Serón, Daniel ⁱ  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

^c ORGANIZACIÓN NACIONAL DE TRASPLANTES   (Spain)

^d HOSPITAL CLÍNIC   (Spain)

^e HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^f HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^g HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^h PFIZER INC   (United States)

ⁱ HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

hepatitis C; proteinuria; renal function; renal transplantation

Indexed keywords

CREATININE; CYCLOSPORIN; HEPATITIS C ANTIBODY; HLA B ANTIGEN; HLA DR ANTIGEN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CREATININE BLOOD LEVEL; DELAYED GRAFT FUNCTION; DIALYSIS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; GLOMERULONEPHRITIS; GLOMERULOPATHY; GLOMERULUS FILTRATION RATE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEPATITIS C; HLA MATCHING; HUMAN; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEINURIA; RISK FACTOR; SURVIVAL RATE;

EID: 77956035389     PISSN: 17530784     EISSN: 17530792     Source Type: Journal    
DOI: 10.1093/ndtplus/sfq070     Document Type: Article

References (17)

1. Pereira BJ, Levey A. Hepatitis C in organ transplantation: its significance and influence on transplantation policies. Curr Opin Nephrol Hypertens 1993; 2: 912-922
2. European Best Practice Guidelines for Renal Transplantation. Section I: evaluation, selection and preparation of the potential recipient. Nephrol Dial Transplant 2000; 15: 3-38
3. KDIGO Clinical Practice Guidelines for the Prevention. Diagnosis, evaluation and treatment of hepatitis C in chronic kidney disease. Kidney Int 2008; 73: S1-S99
4. Covic A, Abramowicz D, Bruchfeld A et al. Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) hepatitis C guidelines: a European Renal Best Practice (ERBP) position statement. Nephrol Dial Transplant 2009; 24: 719-727
5. Morales JM, Dominguez-Gil B, Sanz-Guajardo D et al. The influence of hepatitis B and hepatitis C virus infection in the recipient on late renal allograft failure. Nephrol Dial Transplant 2004; 19: 72-76
6. Fabrizi F, Martin P, Dixit Vet al. Hepatitis C virus antibody status and survival after renal transplantation: meta-analysis of observational studies. Am J Transplant 2005; 5: 1452-1461
7. Gloor J, Sethi S, Stegall MD et al. Transplant glomerulopathy subclinical incidence and association with alloantibody. Am J Transplant 2007; 7: 2124-2132
8. Forman JP, Tolkoff-Rubin N, Pascual M et al. Hepatitis C, acute humoral rejection, and renal allograft survival. J Am Soc Nephrol 2004; 15: 3249-3255
9. Corell A, Morales JM, Mandroño A et al. Immunosuppression induced by hepatitis C virus infection reduces acute renal transplant rejection. Lancet 1995; 346: 1497-1498
10. Hestin D, Guillemin F, Castin N et al. Pre-transplant hepatitis C virus infection: a predictor of proteinuria after renal transplantation. Transplantation 1998; 65: 741
11. Moreso F, Ibernon M, Goma M et al. Subclinical rejection associated with chronic allograft nephropathy in protocol biopsies as a risk factor for late graft loss. Am J Transplant 2006; 6: 747-752
12. Bruchfeld A, Wilczek H, Elinder CG. Hepatitis C infection, time in renal-replacement therapy and outcome after kidney transplantation. Transplantation 2004; 78: 745-750
13. Legendre C, Garrigue V, Le Bihan C et al. Harmful long-term impact of hepatitis C virus infection in kidney transplant recipients. Transplantation 1998; 65: 667-670
14. Mathurin P, Mouquet C, Poynard T et al. Impact of hepatitis B and C virus on kidney transplantation outcome. Hepatology 1999; 29: 257-263
15. Maluf DG, Fisher RA, King Al et al. Hepatitis C virus infection and kidney transplantation: predictors of patient and graft survival. Transplantation 2007; 83: 853-857
16. Kamar N, Rostaing L, Selves J et al. Natural history of hepatitis C virus-related liver fibrosis after renal transplantation. Am J Transplant 2005; 5: 1704-1712
17. Domiguez-Gil B, Morales JM. Transplantation in the patient with hepatitis C. Transpl Int 2009; 22: 117-131